Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$289.50+2.03 (+0.71%)
Close on Nov 18, 2026Market cap $41.73BP/E –Yield –
Natera operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Natera's operating income for the twelve months ending Jun 30, 2026 was -$289.67M. For fiscal 2025 it was -$309.91M. The highest annual figure on record is $665.00K in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$309.91M | – |
| FY2024 | Dec 31, 2024 | -$222.29M | – |
| FY2023 | Dec 31, 2023 | -$446.25M | – |
| FY2022 | Dec 31, 2022 | -$541.04M | – |
| FY2021 | Dec 31, 2021 | -$468.17M | – |
| FY2020 | Dec 31, 2020 | -$216.28M | – |
| FY2019 | Dec 31, 2019 | -$116.29M | – |
| FY2018 | Dec 31, 2018 | -$114.63M | – |
| FY2017 | Dec 31, 2017 | -$135.34M | – |
| FY2016 | Dec 31, 2016 | -$101.05M | – |
| FY2015 | Dec 31, 2015 | -$59.84M | -9098.2% |
| FY2014 | Dec 31, 2014 | $665.00K | – |
| FY2013 | Dec 31, 2013 | -$25.27M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$75.79M | – |
| Q1 FY2026 | Mar 31, 2026 | -$93.52M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$97.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$110.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$79.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$64.74M | – |
| Q3 FY2024 | Sep 30, 2024 | -$39.34M | – |
| Q2 FY2024 | Jun 30, 2024 | -$43.90M | – |
| Q1 FY2024 | Mar 31, 2024 | -$74.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$84.54M | – |
| Q3 FY2023 | Sep 30, 2023 | -$110.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$112.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$138.30M | – |
| Q4 FY2022 | Dec 31, 2022 | -$141.77M | – |
| Q3 FY2022 | Sep 30, 2022 | -$119.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$143.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$137.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$139.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$150.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$115.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$63.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$73.97M | – |
| Q3 FY2020 | Sep 30, 2020 | -$55.78M | – |
| Q2 FY2020 | Jun 30, 2020 | -$51.66M | – |
| Q1 FY2020 | Mar 31, 2020 | -$34.87M | – |
| Q4 FY2019 | Dec 31, 2019 | -$34.81M | – |
| Q3 FY2019 | Sep 30, 2019 | -$21.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$28.64M | – |
| Q1 FY2019 | Mar 31, 2019 | -$31.75M | – |
| Q4 FY2018 | Dec 31, 2018 | -$29.73M | – |
| Q3 FY2018 | Sep 30, 2018 | -$27.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.22M | – |
| Q1 FY2018 | Mar 31, 2018 | -$30.52M | – |
| Q4 FY2017 | Dec 31, 2017 | -$46.63M | – |
| Q3 FY2017 | Sep 30, 2017 | -$25.79M | – |
| Q2 FY2017 | Jun 30, 2017 | -$28.37M | – |
| Q1 FY2017 | Mar 31, 2017 | -$34.55M | – |
| Q4 FY2016 | Dec 31, 2016 | -$42.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$26.66M | – |
See a number that looks wrong?